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Treponema denticola is an important contributor to periodontal disease. In this study we investigated the
ability of T. denticola to bind the complement regulatory proteins factor H and factor H-like protein 1 (FHL-1).
The binding of these proteins has been demonstrated to facilitate evasion of the alternative complement
cascade and/or to play a role in adherence and invasion. Here we demonstrate that T. denticola specifically
binds FHL-1 via a 14-kDa, surface-exposed protein that we designated FhbB. Consistent with its FHL-1
binding specificity, FhbB binds only to factor H recombinant fragments spanning short consensus repeats
(SCRs) 1 to 7 (H7 construct) and not to SCR constructs spanning SCRs 8 to 15 and 16 to 20. Binding of H7
to FhbB was inhibited by heparin. The specific involvement of SCR 7 in the interaction was demonstrated using
an H7 mutant (H7AB) in which specific charged residues in SCR 7 were replaced by alanine. This construct
lost FhbB binding ability. Analyses of the ability of FHL-1 bound to the surface of T. denticola to serve as a
cofactor for factor I-mediated cleavage of C3b revealed that C3b is cleaved in an FHL-1/factor I-independent
manner, perhaps by an unidentified protease. Based on the data presented here, we hypothesize that the
primary function of FHL-1 binding by T. denticola might be to facilitate adherence to FHL-1 present on
anchorage-dependent cells and in the extracellular matrix.
Treponema denticola, a spirochete member of the normal
flora of the oral cavity, is an important contributor to the
development of acute and chronic periodontal disease in hu-
mans (42, 45). It is a dominant species in periodontal lesions
and at the leading front of periodontitis-associated subgingival
plaque (40). Real-time PCR analyses have demonstrated that
there is a strong correlation between the numbers of T. denti-
cola cells and pocket depth in periodontitis patients (45). Adult
periodontitis is the most common infection of middle-aged
adults, and although it is not life threatening, its economic
impact is enormous. In addition to T. denticola, other domi-
nant species associated with periodontitis include Haemophilus
actinomycetecomitans (formerly classified in the genus Acti-
nobacillus), Porphyromonas gingivalis, and Tannerella forsythia
(43). A large number of less-well-characterized species, includ-
ing nearly 60 treponeme phylotypes, have also been implicated
(8). There is also a strong association of T. denticola with
esophageal cancers (30) and with low birth weight in preterm
infants (31).
An expanding number of human pathogens, including sev-
eral spirochete species belonging to the Lyme disease and
relapsing fever Borrelia groups, have been shown to bind the
complement regulatory protein factor H and/or factor H-like
protein 1 (FHL-1) (7, 9, 11, 13, 16, 17, 25, 27–29, 33, 35, 36). In
addition, recombinant Omp100 of H. actinomycetecomitans has
also been demonstrated to bind either factor H or FHL-1 and
to play a role in adherence and invasion of KB cells (4). Factor
H and FHL-1 are comprised of a series of short consensus
repeats (SCRs) consisting of approximately 50 to 60 residues
(reviewed in reference 47). FHL-1 is derived from the factor H
mRNA via alternative splicing and consists of the first seven
SCRs of factor H plus four additional hydrophobic residues at
its C terminus (12, 46). Factor H and FHL-1 regulate the
alternative complement pathway by serving as a cofactors for
factor I-mediated cleavage of C3b (38, 39). In addition, they
inhibit the initial formation and accelerate the dissociation of
the alternative pathway C3 convertase by competing with Bb
for binding to C3b. In terms of bacterial pathogenesis, surface-
bound factor H and FHL-1 are thought to locally increase the
efficiency of C3b cleavage and thereby inhibit opsonization and
phagocytosis. In addition, some pathogens may bind to extra-
cellular matrix or cell-anchored FHL-1 as a means to facilitate
adherence and intracellular localization (33).
In this report, we demonstrate that T. denticola specifically
binds the complement regulatory protein FHL-1. To our
knowledge, this is the first bacterial protein identified that
binds specifically FHL-1 and not factor H. The FHL-1 binding
protein was determined to be surface exposed and to have a
molecular mass of 14 kDa. We tentatively designated this pro-
tein FhbB (FHL-1 binding protein B). Using recombinant fac-
tor H SCR constructs, we showed that the binding of FhbB to
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FHL-1 is inhibited by heparin and is mediated via specific
charged residues in SCR 7. These analyses provide the first
direct evidence for the binding of a complement regulatory
protein to T. denticola and enhance our understanding of the
pathogenic mechanisms of this organism. FHL-1 binding by T.
denticola may represent a potential adherence mechanism and
may play an important role in biofilm formation and develop-
ment of periodontal disease.
MATERIALS AND METHODS
Bacterial strains and cultivation. T. denticola American Type Culture Collec-
tion strains ATCC 35405, ATCC 33520, and ATCC 33521 were cultivated in
NOS medium (ATCC medium 1357) at 37°C in an anaerobe jar with GasPak
Plus (Becton Dickinson and Company, Sparks, MD). Unless otherwise indicated,
all analyses were conducted using the ATCC 35405 strain. B. burgdorferi B31MI,
which served as a control in some analyses, was cultivated at 33°C in complete
BSK-H medium (Sigma, St. Louis, MO). Approximately 5 to 7 days was required
to obtain dense cultures of all strains. Growth was monitored by dark-field
microscopy. The spirochetes were recovered by centrifugation and subjected to
various numbers of washes with phosphate-buffered saline (PBS) as indicated
below.
Factor H and/or FHL-1 absorption assay. T. denticola ATCC 35405 and B.
burgdorferi B31MI (control) cells from 1 ml of a dense culture (109 cells) were
recovered by centrifugation (5,000  g, 10 min, 4°C), washed with cold PBS,
resuspended in 200 l cold PBS containing factor H/FHL-1 (0.525 mg ml1), and
incubated for 1 h at room temperature. The cells were recovered by centrifuga-
tion (3,000  g, 5 min, room temperature), washed twice with cold PBS, solu-
bilized in sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis
(PAGE) sample buffer, electrophoresed, and immunoblotted. The membranes
were then screened using the affinity ligand binding immunoblot (ALBI) assay
with and without addition of factor H/FHL-1 as described below.
ALBI assays and immunoblot analyses. Cell lysates of T. denticola were pre-
pared by solubilization in SDS-PAGE sample buffer and boiling. The proteins
were separated and analyzed by SDS-PAGE using 15% polyacrylamide precast
gels (Bio-Rad). Equal loading of proteins was assessed by Coomassie blue stain-
ing. Proteins were transferred onto Immobilon P membranes (Millipore) by
electroblotting as previously described (24). Factor H/FHL-1 or SCR ALBI
assays were conducted as previously described previously (29) using a prepara-
tion of purified human factor H (Calbiochem) or purified recombinant SCR
constructs (9). The commercial factor H preparation, as reported by the supplier,
contained approximately 95% factor H and 5% FHL-1. In the ALBI assay bound
factor H/FHL-1 was detected using goat anti-human factor H antiserum (1:800
dilution; Calbiochem) with horseradish peroxidase-conjugated rabbit anti-goat
immunoglobulin (IgG) antibody as the secondary antibody (1:40,000 dilution;
Pierce). The goat anti-human factor H antiserum detected factor H, FHL-1, and
all SCR constructs used in these analyses. The three SCR constructs analyzed
spanned SCRs 1 to 7 (H7), SCRs 8 to 15, and SCRs 16 to 20. These constructs
were generated as part of a previous study by Duthy et al. (9). Briefly, the SCRs
of interest were PCR amplified, cloned into the yeast expression vector pPICZ
(Invitrogen), expressed in Pichia pastoris, and purified by immunoaffinity chro-
matography.
Heparin inhibition assays. Immunoblot strips of T. denticola ATCC 35405 cell
lysates were prepared as described above. The SCR 1 to 7 construct, H7, was
preincubated with or without heparin (1 g ml1) in 5% skim milk, PBS with
0.02% Tween 20 (PBS-T) for 30 min at room temperature before addition to the
T. denticola membrane strip for 1 h at room temperature. The blot was washed
with PBS-T for 30 min with three changes of buffer and then analyzed for factor
H/FHL-1 binding using the ALBI assay described above.
IFAs. For indirect immunofluorescence assays (IFAs) slides were prepared
and general procedures were performed as previously described (37). To deter-
mine if FHL-1 bound to the surface of the spirochetes, cells were recovered from
a dense culture of T. denticola by centrifugation (5,000  g, 5 min), washed with
PBS, pelleted by centrifugation (10,000  g, 20 min), and resuspended in 1 ml
PBS with 10% fetal goat serum (PBS-FGS). The motility and hence viability of
the cells were confirmed by dark-field microscopy. Purified factor H/FHL-1 was
added to the cells to a final concentration of 10 ng l1, and the cells were
incubated at 37°C for 1 h with occasional gentle mixing. The cells were washed
with PBS-FGS to remove unbound factor H/FHL-1, resuspended in 25 l PBS-
FGS, and placed on prepared slides. Bound FHL-1 was detected using goat
anti-human factor H antisera (1:10 dilution; Calbiochem) and ALEXA 488-
conjugated rabbit anti-goat IgG antibody (1:2,000 dilution; Molecular Probes).
As a control to verify that the outer membrane was not disrupted by these
procedures, a second slide was stained for the periplasmic protein FlaA. FlaA
was detected by incubation with rabbit anti-FlaA (a kind gift from Chris Fenno)
at a dilution of 1:10,000, followed by incubation with ALEXA 488-conjugated
goat anti-rabbit IgG antibody (1:2,000 dilution). As a final control, T. denticola
cells were acetone fixed and permeabilized before they were screened with the
anti-FlaA antiserum as described above. Images were captured using a Mag-
naFire camera and software (Olympus).
C3b cleavage assay. The ability of factor H/FHL-1 bound to T. denticola
ATCC 35405 to cleave C3b was assessed using a C3b cleavage assay described
previously (23). In brief, cultures of T. denticola were pelleted, washed with
ice-cold PBS, resuspended in cold PBS with 10 mM MgCl2, and incubated with
0 or 50 ng of purified human factor H/FHL-1 for 1 h at 37°C. The cells were
washed with PBS to remove unbound factor H/FHL-1. Factor I (150 ng; Calbio-
chem) and C3b (250 ng; Calbiochem) were then added, and the mixture was
incubated for 2 h at 37°C. The samples were fractionated by SDS-PAGE, im-
munoblotted, and screened with anti-human C3b antiserum (1:800 dilution;
Accurate). The immunoblot methods used have been described previously (25).
As additional controls for the reaction conditions employed, various combina-
tions of purified factor H/FHL-1 (150 ng), factor I (150 ng), and/or C3b (250 ng)
were incubated at 37°C in PBS for 2 h. In addition, T. denticola and B. burgdorferi
were incubated as described above with factor I, factor H/FHL-1, or both omit-
ted from the reaction. The reaction products were analyzed by SDS-PAGE and
Coomassie blue staining.
RESULTS
Assessment of factor H and/or FHL-1 binding to T. denticola.
To determine if T. denticola can bind factor H, FHL-1, or both,
an absorption assay was performed. T. denticola ATCC 35405
was incubated with a purified factor H/FHL-1 preparation.
According to the supplier, the preparation contained approx-
imately 95% factor H and 5% FHL-1. After washing to remove
unbound factor H/FHL-1, the cells were solubilized, and the
resulting cell lysates were fractionated by SDS-PAGE and im-
munoblotted. Screening of the blots with anti-factor H/FHL-1
antiserum demonstrated that FHL-1 and an unidentified 37-
kDa protein were absorbed by T. denticola (Fig. 1A). The
37-kDa protein may have been FHR-1 or, alternatively, a deg-
radation product of FHL-1 generated by one of the many
proteases produced by T. denticola (5, 6, 21). Since reagents
specific for FHR-1 are not available, the identity of this protein
could not be determined. Verification that the anti-factor
H/FHL-1 antiserum was specific and was not binding to trepo-
neme proteins came from the demonstration that T. denticola
that was incubated without factor H/FHL-1 did not react with
the antiserum. It is important to note that in spite of the higher
concentration of factor H in the assay mixture, no detectable
binding of factor H was observed. FHL-1 was significantly
concentrated by absorption, as shown by the fact that it was
only weakly detected in the control lane of the purified factor
H/FHL-1 preparation. In contrast to the results observed with
T. denticola, B. burgdorferi absorbed predominantly factor H,
indicating that there was a striking difference in the specificity
of binding to different members of the factor H family by these
spirochetes.
To determine the molecular mass of the FHL-1 binding
protein of T. denticola ATCC 35405 and to determine if it is
produced by other strains, cell lysates of multiple strains were
immunoblotted and screened using the factor H/FHL-1 ALBI
assay. Equal loading of protein in all lanes was determined by
Coomassie blue staining (data not shown). A protein with a
molecular mass of approximately 14 kDa was found to bind
FHL-1. This protein was detected in all T. denticola strains,
although there was some variation in the amount produced.
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The protein was designated FhbB for FHL-1 binding protein B
(Fig. 1B). This designation reflects the function and is consis-
tent with the nomenclature used for the functionally related
FhbA protein of the relapsing fever Borrelia (18, 19). Ho-
mologs of known factor H binding proteins produced by other
spirochetes or bacterial species were not detected in the T.
denticola ATCC 35405 genome sequence. However, this is not
surprising since there is little or no sequence homology among
the factor H binding proteins that have been identified to date.
Instead, conservation is primarily at the structural level, with
coiled-coil motifs appearing to be key critical structural motifs
(22, 24). B. burgdorferi B31MI, which produces multiple factor
H binding proteins (1, 16, 22, 25, 29, 44), served as the positive
control and readily bound factor H.
Demonstration that FhbB of T. denticola ATCC 35405 binds
to SCR 7 and that this interaction is mediated by charged
residues within SCR7. To further assess the specificity of the
interaction of FhbB with FHL-1 and to determine if SCRs 8 to
20 (which are not part of FHL-1) have the potential to bind to
FhbB, recombinant SCR constructs spanning SCRs 1 to 7
(H7), 8 to 15, and 16 to 20 were employed. Only H7 was found
to bind to FhbB (Fig. 2A). This provided further support for
the unique specificity of the interaction of FhbB with FHL-1
but not factor H. Weak binding of the H7 construct to one or
more proteins with molecular masses of approximately 42 kDa
was also observed. These proteins may have been additional
FHL-1 binding proteins, possibly trimers of FhbB, or simply
may have represented nonspecific background.
SCR 7 has three regions with basic residues designated sites
A (R369 and K370), B (R386 and K387), and C (K392) (13).
To determine if charged residues within specific domains of
SCR 7 are involved in binding to FhbB, a site-directed mutant
of the H7 construct designated H7AB that was previously
generated and described by Giannakis et al. (13) was used in
the binding assay. In the H7AB mutant, the charged residues
within sites A and B are replaced with alanine. It has been
demonstrated that H7AB cannot bind heparin (13). H7AB did
not bind to any of the T. denticola FHl-1 binding proteins,
indicating that specific charged residues within site A and/or
site B are necessary for binding.
Inhibition of FHL-1 binding to FhbB by heparin. Since the
charged residues altered in H7AB also mediate heparin bind-
ing, we determined whether heparin can inhibit the binding of
the H7 construct to FhbB. Immunoblot strips of T. denticola
lysate were screened with H7 that had been preincubated with
or without heparin, and binding was assessed using the ALBI
approach. Heparin completely inhibited the binding of H7 to
FhbB (Fig. 2B). The inhibition of FHL-1 binding to FhbB by
heparin, which has been shown to bind to SCR 7, provides
additional support for the hypothesis that FhbB binds directly
to SCR 7.
Demonstration that FhbB of T. denticola is surface exposed.
To indirectly demonstrate that FhbB of T. denticola is surface
exposed, the ability of intact cells to bind FHL-1 to their
surfaces was assessed using indirect immunofluorescence (Fig.
3). Unfixed cells readily bound FHL-1, indicating that the
FHL-1 binding protein is surface exposed. As a control, cells
were also screened with antiserum to the FlaA protein, which
is an inner membrane-anchored protein that resides primarily
in the periplasm. No binding to FlaA was observed in unfixed
cells, but binding was observed in acetone-fixed (permeabil-
ized) cells.
FIG. 1. Detection of an FHL-1 binding protein in T. denticola
ATCC 35405. To determine if factor H or FHL-1 or both can bind to
T. denticola, absorption assays were performed. Whole cells were in-
cubated with purified factor H/FHL-1, recovered by centrifugation,
washed to remove unbound ligand, solubilized, and immunoblotted,
and bound factor H/FHL-1 was detected by immunoblotting using
anti-factor H/FHL-1 antiserum (A). All methods are described in the
text. B. burgdorferi B31MI and purified factor H/FHL-1 served as
positive controls for absorption and immunoblot detection, respec-
tively. The abilities of different T. denticola strains (indicated above the
lanes) to bind FHL-1 and the molecular mass of the binding protein
were determined using the ALBI assay (B). In brief, cell lysates of each
strain were fractionated by SDS-PAGE and immunoblotted. The blots
were incubated with purified factor H/FHL-1 and then screened with
anti-factor H/FHL-1 antiserum. B. burgdorferi B31MI, which produces
multiple factor H binding proteins (BBA68 and OspE), served as the
positive control. The positions of molecular mass markers are indi-
cated on the right.
FIG. 2. Demonstration that SCRs 1 to 7 bind to the FhbB protein
of T. denticola ATCC 35405 and that binding is dependent on charged
residues within SCR 7 and inhibited by heparin. To determine which
SCRs of factor H/FHL-1 can bind to T. denticola, recombinant SCR
constructs were used to screen immunoblot strips using the ALBI assay
format (A). The SCR constructs used to screen the blots are indicated
above the blots. The effects of charged residues within SCR 7 on
binding to T. denticola were assessed using a site-directed mutant of
the SCR 1 to 7 construct, H7AB. The influence of heparin on SCR1 to
7 binding was determined by preincubating the H7 construct with ()
or without () heparin before immunoblot strips of T. denticola lysate
were screened using the ALBI assay (B).
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Analysis of the nature of the interaction of FhbB with the
T. denticola cell surface. The association of FhbB with the
spirochete cell surface was also assessed following successive
washes of actively growing cells with PBS. Cells washed from
zero to four times with PBS were lysed and immunoblotted,
and FHL-1 binding was assessed using the ALBI assay (Fig.
4). With each successive wash, detectable FHL-1 binding to
the resulting T. denticola cell lysates decreased. In contrast,
when identical samples were screened with anti-FlaA anti-
serum, no decrease in FlaA detection by immunoblotting was
observed. The effect of washing on detection of FHL-1 binding
suggests that FhbB is loosely associated with the outer mem-
brane.
Demonstration of FHL-1-independent cleavage of C3b by T.
denticola. To determine whether FHL-1 bound to the surface
of T. denticola is capable of serving as a cofactor in factor
I-mediated cleavage of C3b, an in vitro cleavage assay was
employed (23) (Fig. 5). Cleavage that resulted in the expected
C3b digestion products was observed in the control reactions,
in which factor I and C3b were incubated with the purified
factor H/FHL-1 preparation. In addition, factor H/FHL-1-de-
pendent cleavage of C3b by factor I, which has previously been
demonstrated, was also observed (1, 3, 16, 20, 23). When
FHL-1 was bound to T. denticola and then factor I and C3b
were added, significant digestion of C3b was observed. How-
ever, the pattern of digestion products was inconsistent with
the expected specific cleavage at serine residues of C3b, and
when C3b was incubated with T. denticola alone, significant
cleavage was also observed. C3b cleavage was also observed
with culture supernatant alone. These analyses suggest that T.
denticola produces a factor I-independent protease with C3b
cleavage activity. Furthermore, the data suggest that the pri-
FIG. 3. Demonstration of FHL-1 binding to the surface of T. denticola ATCC 35405 determined by IFAs. IFAs were performed as described
in the text using unfixed and acetone-fixed cells (panels A and B, respectively). The antiserum used in the IFA is indicated below each image where
appropriate. The images in panels A and B were obtained with a 100 (oil immersion) objective. The dark-field image is presented for each
preparation for reference to indicate the location of the spirochetes.
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mary biological function of T. denticola-bound FHL-1 may not
be in immune evasion but perhaps in adherence.
DISCUSSION
Periodontal disease is caused by a complex polymicrobial
population of endogenous bacteria and several host-deter-
mined factors. The bacteria associated with periodontal dis-
ease act in a synergistic fashion to establish a productive pop-
ulation in the subgingiva that tenaciously adheres and invades
host cells and tissues. The host response is characterized by
significant inflammation, a humoral response, and complement
activation within the periodontal pocket (41). In spite of this
robust host response, the bacteria survive and thrive. In this
study we sought to determine whether T. denticola exploits the
binding of the complement regulatory protein factor H and/or
FHL-1 in immune evasion, adherence, or tissue penetration.
Numerous pathogens circumvent the alternate complement
pathway and subsequent opsonophagocytosis by binding factor
H and/or FHL-1 (4, 7, 9, 11, 13, 16, 17, 25, 27–29, 33, 35, 36).
Through a variety of mechanisms, these proteins contribute to
the downregulation of C3b production and locally decrease the
levels of the opsonin C3b. Additionally, and potentially of
great importance in T. denticola pathogenesis, the binding of
FHL-1 by proteins exposed on the surface of group A strep-
tococci have also been shown to facilitate adherence and in-
vasion (33). In light of the ability of T. denticola to adhere to
and persist within periodontal lesions we sought to determine
if T. denticola is capable of binding factor H and/or FHL-1.
As a first step in assessing the binding of complement reg-
ulatory proteins to T. denticola a whole-cell absorption assay
was performed. Viable cells were incubated with a purified
factor H/FHL-1 preparation that consisted of 95% factor H
and 5% FHL-1 (as determined by the supplier). It has not been
determined if other members of the factor H family, such as
the FHR proteins, also copurify with factor H. After incuba-
tion of T. denticola with factor H/FHL-1, the cells were washed
and then analyzed by SDS-PAGE and immunoblotting.
Screening of the immunoblot with the anti-factor H/FHL-1
antiserum demonstrated that the molecular masses of the pro-
teins bound by T. denticola were approximately 43 and 37 kDa.
It is striking that in spite of its higher concentration, no factor
H (150 kDa) was absorbed by T. denticola. In contrast, factor
H, but not FHL-1, was readily absorbed by B. burgdorferi. The
absorption of 37- and 43-kDa proteins suggests that FhbB not
only binds to FHL-1 but may also bind to other members of the
factor H family of proteins, possibly FHR-1. FHR-1 exists as
two forms, FHR-1 (37 kDa) and FHR-1 (43 kDa), and the
difference in mass is due to differences in carbohydrate mod-
FIG. 4. Demonstration that the FHL-1 binding protein of T. den-
ticola ATCC 35405 is loosely associated with the cell surface. To assess
the nature of the interaction of FhbB with the T. denticola cell surface,
T. denticola cells were subjected to one, two, three, or four washes with
PBS after recovery from culture media. Two blots were generated; one
was screened for FlaA protein by immunoblotting (A), and the other
was screened for FHL-1 binding using the ALBI assay (B). B. burg-
dorferi (Bb) B31MI served as the positive control in the ALBI assay.
The positions of molecular mass standards are indicated on the right.
FIG. 5. Demonstration of FHL-1-independent C3b cleavage by T.
denticola ATCC 35405. T. denticola ATCC 35405 and B. burgdorferi
B31MI were incubated with or without factor H/FHL-1 (fH/FHL-1), as
indicated above the lanes. Unbound ligand was removed by washing
with PBS. The cells were then incubated with or without factor I (fI)
and/or C3b as indicated above the lanes, analyzed by SDS-PAGE,
immunoblotted, and screened with anti-C3b antiserum. Additional
controls in which various combinations of purified C3b, factor I, and/or
factor H/FHL-1 were combined and treated as described above were
also included. All methods are described in the text.
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ification (10). However, it is equally plausible that the smaller
bands observed are simply FHL-1 degradation products. Based
on the intensity of the signal observed when the blot was
screened with anti-factor H/FHL-1 antiserum, it is evident that
the stoichiometry of FHL-1 binding to T. denticola is relatively
high, as the cells significantly concentrate this protein. It is
noteworthy that the control for these analyses, B. burgdorferi
B31MI, bound predominantly, if not exclusively, factor H. Ali-
talo and colleagues reported that the B. burgdorferi IA strain
bound both factor H and FHL-1 (2). However, other isolates in
the report of these workers bound only factor H, and based on
this finding and the data presented here it is appears that
FHL-1 binding may vary between Lyme disease spirochete
strains. Since factor H and FHL-1 can have distinct functional
roles, it is likely that Borrelia and T. denticola exploit the
binding of complement regulatory proteins for different purposes.
The number, mass, and distribution among isolates of the T.
denticola FHL-1 binding proteins were determined using the
ALBI assay. An FHL-1 binding protein with a molecular mass
of 14 kDa was detected in all T. denticola strains tested and was
designated FhbB (for FHL-1 binding protein B). A function-
ally related protein, FhbA, has been identified in the relapsing
fever spirochetes (18), and hence the designation FhbB is
intended to be consistent with bacterial protein nomenclature
guidelines, to reflect functional activity, and to provide consis-
tency in the nomenclature of factor H/FHL-1 binding proteins.
The data presented above strongly suggest that FhbB spe-
cifically binds to FHL-1 but not factor H. To verify this, re-
combinant proteins consisting of SCRs 1 to 7, 8 to 15, and 16
to 20 were tested for the ability to bind to FhbB. Only H7
bound to T. denticola. As described above, FHL-1 is comprised
of the first seven SCRs of factor H plus four additional C-
terminal residues. The FhbA protein of Borrelia hermsii (19)
and the group A streptococcal M and Fba proteins also have
been reported to bind specifically to SCRs 1 to 7 (13, 32).
Similar to results obtained for the M and Fba proteins, heparin
inhibited the binding of H7 to T. denticola. Previous studies
identified interaction sites for heparin within factor H SCRs 7,
12, 13, 14, and 20 (47). Hence, the ability of heparin to inhibit
FHL-1 binding to FhbB is consistent with the localization of
both FhbB and heparin interaction sites within SCR 7 of FHL-1.
Previous analyses of the molecular interaction between fac-
tor H and the M protein of group A streptococcus using an
SCR 1 to 7 mutant designated H7AB demonstrated that
charged residues at specific sites in SCR 7 are directly or
indirectly involved in binding (13). In the H7AB mutant, spe-
cific charged residues in SCR 7 were replaced by alanine. The
H7AB mutant was found to be incapable of binding to the M
protein. In this study, we demonstrated that H7AB also could
not bind to FhbB. This finding further confirms the specific
involvement of SCR 7 in binding and the importance of posi-
tively charged residues in the FHL-1/FhbB interaction.
For FHL-1 binding to FhbB to be of biological significance,
FhbB would need to be exposed on the surface of intact cells.
To assess this, several different approaches were employed.
First, intact cells were subjected to treatment with proteinase
K, which should degrade surface proteins but not internal
proteins. This approach has been successfully employed to
demonstrate the surface exposure of several spirochete pro-
teins, including FhbA (factor H binding protein A) of B. herm-
sii ((18). While treatment with proteinase K led to complete
elimination of FHL-1 binding by T. denticola (data not shown),
some digestion of the inner membrane-anchored, periplasmic
FlaA protein was also observed. This suggests that the integrity
of the outer membrane was compromised and that the outer
membrane of T. denticola is labile and fragile. The fragility of
the outer membrane and the apparent loose association of
FhbB with the cell surface were confirmed by analysis of the
FHL-1 binding ability of T. denticola cells that had been sub-
jected to increasing numbers of gentle washes with PBS. With
each successive wash, the amount of FHL-1 bound by the cell
lysate proteins derived from the washed cells decreased signif-
icantly, indicating that FhbB is easily removed by washing. This
observation suggests that FhbB is loosely associated with the
cell surface. Surface exposure and outer membrane localiza-
tion of FhbB were further confirmed by IFA analyses of un-
fixed cells. Direct binding of FHL-1 to the cell surface was
readily demonstrated, and since FhbB is the dominant, if not
only, FHL-1 binding protein produced by T. denticola, it can be
concluded that FhbB is at least partially surface exposed.
The potential of T. denticola surface-bound FHL-1 to par-
ticipate as a cofactor in the factor I-mediated cleavage of C3b
was also assessed in this study. Factor I is a serine protease that
cleaves C3b at its serine residues, yielding a specific cleavage
pattern (14, 26). The C3b cleavage assay employed here was
previously employed by McDowell and colleagues to demon-
strate the complement regulatory activity of factor H bound to
the relapsing fever spirochetes B. hermsii and Borrelia parkeri
and the Lyme disease spirochete, B. burgdorferi (23). When
factor H/FHL-1 was incubated with T. denticola and then
tested for its ability to cleave C3b in the presence of factor I,
the resulting cleavage patterns were atypical and suggested
that cleavage was occurring at non-Ser residues. C3b cleavage
was also observed when C3b was incubated with T. denticola
and factor H/FHL-1 without factor I, demonstrating that C3b
cleavage by T. denticola is not FHL-1 and factor I dependent.
Instead, C3b may be targeted by one or more of the proteases
produced by T. denticola (34). While this observation does not
rule out a role for surface-bound FHL-1 in C3b cleavage, it
suggests that the main biological function of FHL-1 binding by
T. denticola may not be related to complement circumvention.
In summary, T. denticola produces a novel protein, FhbB,
that specifically binds FHL-1 and not factor H. FHL-1 has
been demonstrated to be present on anchorage-dependent cell
types, where it binds to integrin receptors, and to interact with
the extracellular matrix through SCR 4 (15). Our hypothesis is
that T. denticola binds to host cell surface-bound FHL-1 via its
FhbB protein and that this interaction facilitates adherence,
biofilm formation, and possibly tissue penetration. Additional
studies are now under way to further characterize FhbB and to
define its relative contribution to the molecular pathogenesis
of T. denticola and periodontal disease.
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